Barclays’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.39M | Buy |
473,658
+262,035
| +124% | +$1.32M | ﹤0.01% | 2114 |
|
|
2025
Q1 | $1.37M | Sell |
211,623
-9,555
| -4% | -$61.9K | ﹤0.01% | 2284 |
|
|
2024
Q4 | $1.62M | Sell |
221,178
-329,008
| -60% | -$2.42M | ﹤0.01% | 2344 |
|
|
2024
Q3 | $4.12M | Buy |
550,186
+7,287
| +1% | +$54.6K | ﹤0.01% | 1668 |
|
|
2024
Q2 | $4.83M | Sell |
542,899
-471,780
| -46% | -$4.2M | ﹤0.01% | 1198 |
|
|
2024
Q1 | $10.3M | Buy |
1,014,679
+569,985
| +128% | +$5.77M | ﹤0.01% | 1015 |
|
|
2023
Q4 | $4.48M | Buy |
444,694
+32,533
| +8% | +$327K | ﹤0.01% | 1571 |
|
|
2023
Q3 | $3.86M | Buy |
412,161
+228,634
| +125% | +$2.14M | ﹤0.01% | 1293 |
|
|
2023
Q2 | $4.5M | Sell |
183,527
-48,975
| -21% | -$1.2M | ﹤0.01% | 1286 |
|
|
2023
Q1 | $5.41M | Buy |
232,502
+36,277
| +18% | +$844K | ﹤0.01% | 1037 |
|
|
2022
Q4 | $4.97M | Sell |
196,225
-43,263
| -18% | -$1.09M | ﹤0.01% | 1124 |
|
|
2022
Q3 | $4.62M | Buy |
239,488
+210,711
| +732% | +$4.06M | 0.01% | 1145 |
|
|
2022
Q2 | $734K | Sell |
28,777
-72,114
| -71% | -$1.84M | ﹤0.01% | 2290 |
|
|
2022
Q1 | $2.6M | Buy |
+100,891
| New | +$2.6M | ﹤0.01% | 1586 |
|